| __timestamp | CRISPR Therapeutics AG | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 79435000 |
| Thursday, January 1, 2015 | 12573000 | 162644000 |
| Friday, January 1, 2016 | 42238000 | 237939000 |
| Sunday, January 1, 2017 | 69800000 | 168435000 |
| Monday, January 1, 2018 | 113773000 | 173797000 |
| Tuesday, January 1, 2019 | 179362000 | 113842000 |
| Wednesday, January 1, 2020 | 266946000 | 747027000 |
| Friday, January 1, 2021 | 438633000 | 2534508000 |
| Saturday, January 1, 2022 | 461645000 | 1235278000 |
| Sunday, January 1, 2023 | 387332000 | 737502000 |
Igniting the spark of knowledge
In the rapidly evolving biotech industry, research and development (R&D) investments are crucial for innovation and growth. This analysis compares the R&D spending of CRISPR Therapeutics AG and Novavax, Inc. from 2014 to 2023. Over this period, Novavax's R&D expenses surged by over 900%, peaking in 2021, driven by its pivotal role in vaccine development. Meanwhile, CRISPR Therapeutics AG, a leader in gene-editing technology, increased its R&D budget by approximately 25,500% from 2014 to 2022, reflecting its commitment to advancing genetic therapies.
These trends underscore the strategic importance of R&D in maintaining competitive advantage and driving innovation in the biotech sector.
Comparing Innovation Spending: Gilead Sciences, Inc. and Novavax, Inc.
Teva Pharmaceutical Industries Limited vs Novavax, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: United Therapeutics Corporation vs CRISPR Therapeutics AG
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Mesoblast Limited
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Mesoblast Limited and Novavax, Inc.